New cocktail therapy aims to shrink tough lung cancers
NCT ID NCT07538271
First seen Apr 21, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This study tests a combination of drugs (benmelstobart, anlotinib, and chemo) followed by chest radiation as a first treatment for people with extensive-stage small cell lung cancer that has spread. About 33 adults aged 18-75 will receive the treatment to see if it shrinks tumors and how safe it is. The goal is to control the disease and delay progression, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLC, EXTENSIVE STAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.